Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Hans Christian Hagedorn is a professor of German and Comparative Literature at Universidad de Castilla-La Mancha (Spain). Born in Bremen (Germany), he studied at the Universities of Hamburg, Münster ...